Centre for Commercialisation of Regenerative Medicine Australia (CCRM)

10 11 BUSINESS VIEW OCEANIA VOLUME 4, ISSUE 7 BUSINESS VIEW OCEANIA VOLUME 4, ISSUE 7 CCRM Australia is working with several partner organisations on a Cooperative Research Centre bid for the RM sector. The Cooperative Research Centres (CRC) Program is an Australian Government-led initiative that has funded collaboration between industry leaders, researchers, and end users since its beginnings in 1990. CRC Australia offers support via two streams: Centre grants that support medium to long-term (up to a decade) collaborations and Centre Project grants that support short-term (up to three years) collaborative research. Mr Tiziani elaborates, “We have been encouraged by our network to lead a bid to establish a CRC called the Solutions for Manufacturing Advanced Regenerative Therapies, or the SMART CRC. This CRC will look at the major challenges facing RM and, if successful, be a 10-year program of activity to help solve them.” CCRM Australia would like to extend heartfelt thanks to several of its collaborative partners, including St Vincent’s Hospital, the CSIRO, Engineering is the future of medicine The Aikenhead Centre for Medical Discovery (ACMD) is a $206 million global biomedical research and training centre co-located at St Vincent’s Hospital Melbourne, in Fitzroy. At ACMD, we are harnessing the power of engineering to transform the future of medicine. “We’re bringing together the best and brightest minds - engineers, researchers, clinicians and allied health professionals - to develop and commercialise devices that will solve some of the world’s toughest healthcare challenges in a way that has never been done before,” said Dr Erol Harvey, CEO ACMD. ACMD is a collaboration between leading universities, research institutes, a tertiary hospital and industry partners. It’s strategic location on a hospital campus provides researchers with access to both public and private patients to undertake benchtop to bedside trials. “The key point of difference of ACMD is its collaborative, structured approach to innovation. The unique model assists the 100+ research projects being undertaken by our partners to move through the development pathway, successfully into their first human trials, and smoothly to implementation,” said Dr Erol Harvey. Diseases and conditions that challenge us now and increasingly into the future include: • epilepsy • osteoarthritis • diabetes • traumatic joint injury • cancer Experts in mechanical, electronic, robotic and digital and data engineering have begun creating smart devices, implantables and technology that will vastly improve the quality of life for people living with serious illness. We are expanding our networks to work with corporate partners and industry both within Australia and internationally to develop active partnerships. For more information, please visit www.acmd.org.au StemCore provides cost effective research tools and services in pluripotent stem cell biology, gene-edited cell lines and quality documentation to advance scientific discoveries for the academic and industry communities. Advancing human stem cell research www.stemcore.com.au stem.core@uq.edu.au @StemCoreAus In partnership with The University of Queensland CCRM